S&P 500
5,911.69
-0.0%
-$0.48
DJI
42,270.07
+0.1%
+$54.34
NASDAQ
19,113.77
-0.3%
-$62.11
Bitcoin
104,141.00
-1.4%
-1,509.68
AAPL
$201.47
+0.8%
+$1.52
AMZN
$205.07
-0.3%
-$0.63
GOOG
$173.06
+0.1%
+$0.10
META
$648.23
+0.5%
+$3.18
MSFT
$460.71
+0.4%
+$2.03
NVDA
$135.22
-2.9%
-$3.97
TSLA
$346.82
-3.2%
-$11.61
Bob Chandler
grahamsway
A dedicated Graham-style value man, Bob bought his first stock in 1986 and though he’s a miserable market timer, longer-term calls let him earn a meager living from his investments. With an MBA and MS in Accounting, Bob relies more on Hetty Green's advice for successful investing: "Buy cheap and sell dear. Act with thrift and shrewdness and be persistent."
Recent Articles by Bob Chandler

Jul 2, 2014
by Bob Chandler
Who Will Win the Lightweight Vehicle Transition?
Car and truck makers are looking to produce lighter vehicles. While they've traditionally used mostly steel, delivered by firms such as U.S. Steel, less weighty aluminum or advanced composites, supplied by companies like Alcoa and Hexcel Corp., are increasingly being employed. Which material provider will win the lightweight vehicle transition?

Jun 17, 2014
by Bob Chandler
3 Stocks That Could Gain From a Natural Gas Drilling Revival
An increase in natural gas drilling may be coming. But who will gain the most from such a resurgence? While producers would likely get a boost, service providers such as Baker Hughes, National Oilwell Varco, or Superior Energy Services could prosper the most.

Jun 2, 2014
by Bob Chandler
Are Chinese Energy Producers a Good Choice for Income Investors?
The search for yield has forced investors to look in some unfamiliar places. Generous payouts, seemingly backed by a national interest, may make major Chinese oil and gas producers like China Petroleum & Chemical, PetroChina, and CNOOC intriguing considerations for those seeking greater portfolio income.

May 27, 2014
by Bob Chandler
Clearing the Confusion About Gasoline Retailing
It seemed pretty clear. The oil and gas industry was intent on divesting its gasoline retailing businesses. Then Energy Transfer Partners and Marathon Petroleum made some significant buys in the sector. Has something changed? Is gasoline retailing now a business to be desired?

May 16, 2014
by Bob Chandler
Can Activist Investing Boost Shares of This Canadian Energy Producer?
Talisman Energy has been an oil and gas sector underperformer, but activist investor Carl Icahn thinks it has some potential. It's an opinion similar to his initial take on Chesapeake Energy, where the share price has almost doubled since he first became involved. With a 7%-plus stake and two seats on the board of directors, can Mr. Icahn’s activism unlock similar shareholder value at Talisman?

May 15, 2014
by Bob Chandler
Why Investors Should Treat This Pipeline MLP With Caution
The recent suspension of Boardwalk Pipeline Partner's major expansion project looks like it could significantly hinder the MLP's future results. Investors may be better served by higher-priced competitors offering greater growth possibilities, like The Williams Companies or Kinder Morgan.

Apr 18, 2014
by Bob Chandler
Are Refining Stocks Headed for Tough Times?
Investors may want to be cautious on shares of refiners. Though recent share price advances may suggest otherwise, there is evidence that companies like Valero Energy, Tesoro Corp. and Marathon Petroleum could find profits harder to achieve longer-term.

Apr 14, 2014
by Bob Chandler
Laboratory Service Providers Should Profit From This New Revenue Source
Legacy laboratory service providers such as Laboratory Corporation of America and Quest Diagnostics have found growth hard to come by recently. But a new revenue source may provide these "old school" medical diagnostics specialists with a surprisingly lucrative future.

Mar 31, 2014
by Bob Chandler
Why Russia's Expansion Into Ukraine Could Be Good for Fertilizer Producers
Russia’s advance into Ukraine has sobered the general stock market. Concern over a major conflict with a world power is probably prudent. But Moscow's encroachment may end up being good news for North American fertilizer producers like Potash Corporation, The Mosaic Company, and Agrium.

Mar 17, 2014
by Bob Chandler
Are You Ready for an Offshore Drilling Buying Opportunity?
Shares of offshore drillers like Ensco, Noble, and Transocean have greatly underperformed the market over the last year. More bad news may be on the way, but there are some compelling reasons why further price declines might represent a great buying opportunity.

Mar 7, 2014
by Bob Chandler
Will My Change of Heart on This High-Yielding Energy Producer Pay Off?
I've always been tempted by LINN Energy's high yield, but long-term concerns significantly depressed its investment appeal. A shrewd acquisition and an attractive valuation, compared to peers like Denbury Resources and Cimarex Energy, have made me more bullish on LINN Energy recently. Will this change of heart ultimately pay off?

Mar 3, 2014
by Bob Chandler
Is This Hospital Stock Undervalued?
Tenet Healthcare shares took a beating recently after missing analyst expectations. But the selling may have been overdone. Compared to peers like HCA Holdings and LifePoint Hospitals, Tenet may be a compelling investment consideration. Here are two reasons to check into this hospital stock.

Feb 28, 2014
by Bob Chandler
3 Ways Utilities Can Deliver More Than Just Dividends
Utility stocks don't usually produce huge capital gains, but under certain circumstances, substantial returns can become more likely. Utilities PG&E, Northeast Utilities, and Sempra Energy have all delivered meaningful stock price gains to astute investors. Here's how they did it.

Feb 24, 2014
by Bob Chandler
Are Iron Ore Stocks About to Face Another Downturn?
Iron ore mining stocks have bounced nicely off their 52-week lows. But increased ore supplies and possible falling demand may not bode well for miners like BHP Billiton, Rio Tinto, and Cliffs Natural Resources. Are these iron ore producers about to encounter another downturn?

Feb 23, 2014
by Bob Chandler
Is This Drug Maker’s Stock Too Cheap to Ignore?
Teva Pharmaceutical shares have under performed its sector over the past year. Though the company faces a number of issues, most of the bad news may already be priced into the stock. Given the drug maker also appears to have some intriguing opportunities for future growth, are Teva shares too cheap to ignore?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.